31-08-2023 02:11 via drugs.com

Monthly News Roundup - August 2023

FDA Approves Zurzuvae, First Oral Treatment for Postpartum Depression
In August, the U.S. Food and Drug Administration (FDA) cleared Zurzuvae (zuranolone) from Sage Therapeutics / Biogen. Zurzuvae is the first FDA-approved oral agent to treat...
Read more »